Table 2.2.
Subgroup analysis for tumor response in patients with stage IB1-IVB
Stage | Parameter | N (%) |
---|---|---|
IB1-IVA | Complete Response (CR) | 4 (11.1) |
Partial Response (PR) | 28 (77.8) | |
Stable Disease (SD) | 1 (2.8) | |
Progressive Disease (PD) | 3 (8.3) | |
ORR (CR + PR), 95%CI | 32 (88.9), 73.9–96.9 | |
DCR (CR + PR + SD), 95%CI | 33 (91.7), 77.5–98.2 | |
IVB | Complete Response (CR) | 5 (13.5) |
Partial Response (PR) | 22 (59.5) | |
Stable Disease (SD) | 6 (16.2) | |
Progressive Disease (PD) | 4 (10.8) | |
ORR (CR + PR), 95%CI | 27 (73.0), 55.9–86.2 | |
DCR (CR + PR + SD), 95%CI | 33 (89.2), 74.6–97.0 |
Data are presented as N (%) unless otherwise specified. Responses were assessed in accordance with RECIST version 1.1. Only confirmed responses were included
ORR, overall response rate; DCR, disease control rate; CI, confidence interval